Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
Sarana Meditama Metropolitan (SAME) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp130.20 Billion) by net assets (Rp4.18 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sarana Meditama Metropolitan - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blackrock Silver Corp
OTCQX:BKRRF
|
-0.284x |
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
-0.327x |
|
Takkt AG
XETRA:TTK
|
0.023x |
|
Viatron Technologies Inc
KQ:141000
|
-0.048x |
|
Taipei Star Bank
TWO:5863
|
-0.366x |
|
Thaivivat Holdings Public Company Limited
BK:TVH
|
N/A |
|
Brightek Optoelectronic Co Ltd
TW:5244
|
0.033x |
|
K N Kenanga Holdings Bhd
KLSE:6483
|
0.110x |
Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2024)
The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp4.14 Trillion | Rp263.42 Billion | 0.064x | +67.33% |
| 2023-12-31 | Rp3.98 Trillion | Rp151.55 Billion | 0.038x | +1481.24% |
| 2022-12-31 | Rp3.98 Trillion | Rp9.58 Billion | 0.002x | -95.80% |
| 2021-12-31 | Rp4.43 Trillion | Rp253.74 Billion | 0.057x | +244.24% |
| 2020-12-31 | Rp545.82 Billion | Rp-21.67 Billion | -0.040x | -120.60% |
| 2019-12-31 | Rp977.50 Billion | Rp188.40 Billion | 0.193x | +716.24% |
| 2018-12-31 | Rp1.33 Trillion | Rp31.31 Billion | 0.024x | -62.85% |
| 2017-12-31 | Rp1.04 Trillion | Rp66.26 Billion | 0.064x | -56.32% |
| 2016-12-31 | Rp850.97 Billion | Rp123.85 Billion | 0.146x | +10.60% |
| 2015-12-31 | Rp741.18 Billion | Rp97.53 Billion | 0.132x | -77.37% |
| 2014-12-31 | Rp191.08 Billion | Rp111.12 Billion | 0.582x | +3.41% |
| 2013-12-31 | Rp133.01 Billion | Rp74.80 Billion | 0.562x | -80.36% |
| 2012-12-31 | Rp19.22 Billion | Rp55.04 Billion | 2.863x | +137.81% |
| 2011-12-31 | Rp-4.05 Billion | Rp30.64 Billion | -7.573x | -- |